Área Sanitaria de Santiago de Compostela e Barbanza
Área sanitaria
University of Texas Southwestern Medical Center
Dallas, Estados UnidosPublicacións en colaboración con investigadores/as de University of Texas Southwestern Medical Center (22)
2023
2022
-
A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function
Kidney International, Vol. 101, Núm. 1, pp. 174-184
-
European Association of Urology Section of Urolithiasis and International Alliance of Urolithiasis Joint Consensus on Retrograde Intrarenal Surgery for the Management of Renal Stones
European Urology Focus, Vol. 8, Núm. 5, pp. 1461-1468
-
Management of early treated adolescents and young adults with phenylketonuria: Development of international consensus recommendations using a modified Delphi approach
Molecular Genetics and Metabolism, Vol. 137, Núm. 1-2, pp. 114-126
2021
-
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
Annals of the Rheumatic Diseases, Vol. 80, Núm. 9, pp. 1137-1146
-
Effects of dapagliflozin on mortality in patients with chronic kidney disease: A pre-specified analysis from the DAPA-CKD randomized controlled trial
European Heart Journal, Vol. 42, Núm. 13, pp. 1216-1227
-
Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection
BJS Open
2019
-
Author Correction: Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (Nature Genetics, (2019), 51, 3, (414-430), 10.1038/s41588-019-0358-2)
Nature Genetics
-
Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen
Nature Communications, Vol. 10, Núm. 1
-
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
Nature Genetics, Vol. 51, Núm. 3, pp. 414-430
-
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial
The Lancet, Vol. 394, Núm. 10204, pp. 1169-1180
2018
-
Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies
Rheumatology and Therapy, Vol. 5, Núm. 2, pp. 567-582
2017
-
Dose Calculation
Emerging Technologies in Brachytherapy (CRC Press), pp. 55-78
-
Estimating the prevalence of generalized and partial lipodystrophy: Findings and challenges
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol. 10, pp. 375-383
-
Three-dimensional printed models for surgical planning of complex congenital heart defects: An international multicentre study
European Journal of Cardio-thoracic Surgery, Vol. 52, Núm. 6, pp. 1139-1148
2016
-
Endolysosomal two-pore channels regulate autophagy in cardiomyocytes
Journal of Physiology, Vol. 594, Núm. 11, pp. 3061-3077
-
The diagnosis and management of lipodystrophy syndromes: A multi-society practice guideline
Journal of Clinical Endocrinology and Metabolism, Vol. 101, Núm. 12, pp. 4500-4511
2015
-
Ghrelin
Molecular Metabolism, Vol. 4, Núm. 6, pp. 437-460
-
Mudd's disease (MAT I/III deficiency): A survey of data for MAT1A homozygotes and compound heterozygotes
Orphanet Journal of Rare Diseases, Vol. 10, Núm. 1
2014
-
Analysis of infections and all-cause mortality in phase II, phase III, and long-term extension studies of tofacitinib in patients with rheumatoid arthritis
Arthritis and Rheumatology, Vol. 66, Núm. 11, pp. 2924-2937